BASF Reports Modest Third Quarter Decline Amid Global Market Caution
On October 30, 2025, BASF released Q3 results, showing a 3% decline in sales to €14.3 billion and EBITDA of €1.5 billion, slightly below the previous year.
BASF’s leadership noted that customer purchasing behavior remains cautious across industries and regions. Sales were affected by adverse currency effects, particularly involving the USD, RMB, and INR, as well as price declines in chemicals, materials, industrial solutions, and agricultural solutions.
Adjusted EBITDA remained relatively stable at 10%, while net income was €172 million, down from €287 million last year. BASF has also initiated a share buyback program up to €1.5 billion, signaling confidence in the company’s underlying value.
The company maintained its full-year guidance for adjusted EBITDA at €6.7–7.1 billion, reflecting a stable outlook despite challenging global conditions.
2026-09-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
INEOS Inovyn Moths Methyl Chlorocarbonate Production Facility in Tavaux, France
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Sinopec Builds 146 Hydrogen Refueling Stations, Ranking Among the World’s Largest Operators
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
BASF Partners with Sinopec to Accelerate Application of Biomethane at Nanjing
-
After Two Price Hikes in One Week, Dow Has Fully Exposed the Most Sensitive Nerve in Europe’s Polyurethane Market
-
Hengli Petrochemical’s Dalian Refinery Sanctioned by the U.S.
-
Middle East Conflict Pushes Up Costs as Dow Warns the Chemical Industry Faces a Tougher Period
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
Recommend Reading
-
“Falling Revenue, Soaring Profits”: Is AkzoNobel’s Financial Alchemy Real Muscle—or Just Smoke and Mirrors?
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
-
Early September: Cost-driven cyclohexanone prices move upward
-
Petroleum Coke Prices in Local Refineries Decline in Mid-September
-
Business Society’s DOP Trend Analysis for September 11, 2026: Clearly Upward
-
April MTBE Market Trends Fluctuate and Decline in China
-
Intensifying Long and Short Positions in Lithium Carbonate, Market Trends Downward
- Hot Searches
- ss 31 peptide for sale
- tirzepatide research peptide for sale online
- is miconazole nitrate the same as miconazole
- chemical manufacturing news
- where can i get retatrutide peptide
- diegonest
- best place to buy retatrutide peptides online
- 2cb buy
- 2cb buy online
- where to buy anhydrous ammonia
- sodium chloride msds
- zirconium silicate